drugset / Trial / NCT00707642
Safety Study of HBV-002 West Nile Vaccine in Healthy Adults
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The purpose of this Phase 1 trial is to evaluate the clinical safety of HBV-002 vaccine in healthy adults.
Timeline
- Start
- 2008-05
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | WN-80E | Vaccine | 5 ug | — |
| Subject | WN-80E | Vaccine | 15 ug | — |
| Subject | WN-80E | Vaccine | 50 ug | — |